Glenmark Pharmaceuticals informs about press release

04 Mar 2026 Evaluate
Glenmark Pharmaceuticals has informed that, Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation. The press release in this regard is attached.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2040.10 -83.40 (-3.93%)
04-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1749.35
Dr. Reddys Lab 1291.15
Cipla 1312.65
Zydus Lifesciences 896.55
Lupin 2304.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×